Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CURE

Explore full profile

Building the "one-stop-shop" platform for healthcare

Berlin, GermanyFounded 2007Health Tech & Medtech
Valuation $50–100M Last recorded · 2022
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for CURE and the history behind them.

About CURE

CURE operates within the health technology sector, specifically targeting the digital transformation of local pharmacies. The company provides a B2B solution aimed at integrating brick-and-mortar pharmacies into the digital economy. At the core of its offering is the CURE Order Platform, which functions as an AI-powered Co-Pilot. This platform enables pharmacies to connect with a network of third-party service providers, thereby streamlining their operational workflows.

The business model appears to be centered on facilitating revenue growth for its pharmacy clients. By integrating with various services, the platform allows pharmacies to manage their business operations more efficiently and access new market channels. This suggests a focus on optimizing backend processes, from inventory management to order fulfillment, through a centralized digital hub. The clients are independent and local pharmacies seeking to modernize their services and compete in an increasingly digital marketplace.

The service is designed to bridge the gap between traditional pharmacy operations and modern e-commerce expectations. By using the CURE platform, pharmacies can expand their service offerings and enhance their delivery capabilities. This system aims to improve how pharmacies manage their business, from handling prescriptions to coordinating with delivery services, ultimately enhancing the end-customer experience without the pharmacy needing to build the digital infrastructure from scratch.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2007
Headquarters
Berlin, Germany
Employees
22
Open positions
None listed
Dealroom signal
64.8/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Hard Tech
Business model
Marketplace & ecommerce
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Sep 2022 $17M $66M Abstract Ventures · Breega · J12 Ventures · Pi Labs ↗
SEED✓Equity / VC Feb 2022 $4.4M $18M Abstract Ventures · J-Ventures · Craft Ventures · J12 Ventures —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

CURE website traffic

Latest recorded traffic for CURE is 1.8K monthly website visits, up 119.5% over the last three months. CURE's team declined 4.3% over the past year.

Latest monthly visits1.8K 3-month web change+119.5% 1-year team growth-4.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

Series A2 investors entered at this stage

  • Breega
  • Pi Labs

Other known investors1 additional known investor

  • Adam Jafer
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇮🇳 India42.9%
🇩🇪 Germany28.6%
🇸🇪 Sweden14.3%
🇹🇳 Tunisia7.1%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CURE on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CURE’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.